Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Single-cell transcriptomics identifies regulatory T cell heterogeneity in gestational diabetes mellitus.
PMID 41933176 · PMC13223204 · Communications medicine · 2026 · 8 claims · 8 setups
Treg cluster proportions do not significantly differ between GDM and healthy control patients
-
Full-text index only
Computational analysis of multi-omics data reveals CXCL10(+) DC-Treg interaction drives immunosuppressive microenvironment in AFP-positive hepatocellular carcinoma.
PMID 41854876 · PMC13038760 · Cellular and molecular life sciences : CMLS · 2026 · 8 claims · 8 setups
STMN1+ and AFP+ malignant cell subsets are enriched in AFP-positive HCC, while CYP3A4+ malignant cells are enriched in AFP-negative HCC
-
Has reproduction · 87
Analysis of Tumor-Infiltrating T-Cell Transcriptomes Reveal a Unique Genetic Signature across Different Types of Cancer.
PMID 36232369 · PMC9569723 · International journal of molecular sciences · 2022 · 8 claims · 8 setups
Common genes shared across five cancer types differ from those found in nonmalignant tissue-resident T-cells for each subset (CD4-T, CD8-T, Treg)
-
Has reproduction · 40
PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127(+) and KLRG1(+) CD8 T cells.
PMID 37231145 · PMC10213055 · NPJ precision oncology · 2023 · 8 claims · 5 setups
NAPC produces higher major pathological response (MPR) and pathological complete response (pCR) rates and longer DFS/OS than NAC alone
-
Full-text index only
Metabolic adaptations rewire CD4(+) T cells in a subset-specific manner in human critical illness with and without sepsis.
PMID 41540263 · PMC12864044 · Nature immunology · 2026 · 8 claims · 7 setups
CD4+ T cells in critical illness show subset-specific metabolic plasticity, with regulatory T (Treg) cells preferentially acquiring glycolytic capacity
-
Full-text index only
Dissecting glioblastoma risk signatures in the tumor immune microenvironment based on multi-dimensional transcriptomics.
PMID 41880523 · PMC13154832 · GigaScience · 2026 · 7 claims · 8 setups
Hallmarks of malignancy and cell cycle regulatory pathways are consistently enriched across single-cell, bulk, and spatial transcriptomic modalities, promoting tumor cell proliferation and progression.
-
Full-text index only
Translation factor eIF4G2 directs CD8(+) T cell lineage commitment by selectively enabling the IL-7 receptor response.
PMID 41940334 · PMC13049607 · iScience · 2026 · 8 claims · 8 setups
eIF4G2 expression is markedly upregulated in DP thymocytes relative to DN thymocytes
-
Full-text index only
Loss of Chromosome Y Associates With Altered Immune Cell Trajectories and X-Inactivation Features.
PMID 42070154 · PMC13135724 · Aging cell · 2026 · 8 claims · 5 setups
LOY has cell type-specific effects on immune cells, with the highest prevalence in classical monocytes, that vary along differentiation trajectories
-
Full-text index only
Gene regulatory network determinants of rapid recall in human memory CD4(+) T cells.
PMID 41865369 · PMC13207208 · Cell reports · 2026 · 8 claims · 6 setups
Memory CD4+ T cells show enhanced chromatin accessibility proximal to rapid-recall genes compared to naive cells
-
Has reproduction · 71
Utilizing the codon adaptation index to evaluate the susceptibility to HIV-1 and SARS-CoV-2 related coronaviruses in possible target cells in humans.
PMID 36760235 · PMC9905242 · Frontiers in cellular and infection microbiology · 2022 · 8 claims · 8 setups
CAI is positively correlated with translational efficiency, validating its use as a proxy for translational efficiency at the elongation level.
-
Has reproduction · 72
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).
PMID 38897205 · PMC11293361 · Cell reports. Medicine · 2024 · 8 claims · 8 setups
Neoadjuvant sintilimab plus carboplatin/nab-paclitaxel is clinically feasible and tolerable in resectable EGFR-mutant NSCLC, with all 18 patients completing treatment and undergoing radical surgery.
-
Full-text index only
Prophylactic Inhaled Pattern Recognition Receptor Agonists Reprogram Lung Epithelial Response and Prevent Type 2 Allergic Inflammation.
PMID 41891295 · PMC13022946 · European journal of immunology · 2026 · 8 claims · 7 setups
Pam2ODN pretreatment reduces airway Th2 polarization and eosinophilic inflammation without affecting Th1, Th17, or Treg responses
-
Full-text index only
The landscape of responses to neoadjuvant immunotherapy in resectable Kirsten rat sarcoma viral oncogene homolog-mutant lung adenocarcinoma: Clinical heterogeneity and correlative immunologic analysis.
PMID 42011021 · PMC13096693 · Clinical and translational medicine · 2026 · 6 claims · 8 setups
KRAS-mutant LUAD patients show significantly poorer pathological response and inferior long-term survival after neoadjuvant immunotherapy compared to KRAS-wildtype patients